Cristina Martín-Sabroso (Cristina Martin-Sabroso)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Pharmaceutics

Pharmaceuticals (Basel, Switzerland)

Universidad Complutense de Madrid

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid Oct 01 2018

Spain

Profesor ayudante doctor :: Farmacia Galénica y Tecnología Alimentaria

Publications

Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Laura Gómez-Lázaro, Cristina Martín-Sabroso, Juan Aparicio-Blanco, Ana Isabel Torres-Suárez
Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols. Pharmaceutics 16 (1) (2024)
Cristina Martín-Sabroso, Mario Alonso-González, Ana Fernández-Carballido, Juan Aparicio-Blanco, Damián Cordoba-Diaz, Federico Navarro-García, Manuel Córdoba, Ana Isabel Torres-Suárez
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Cristina Martín-Sabroso, Irene Lozza, Ana Isabel Torres-Suárez, Ana-Isabel Fraguas-Sánchez
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics 13 (10) (2021)
Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Mario Alonso-González, Ana Fernández-Carballido, Ana-Isabel Fraguas-Sánchez
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives. Pharmaceutics 14 (1) (2021)
Ana-Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martín-Sabroso, Ana Fernández-Carballido
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics 12 (5) (2020)

Cristina Martín-Sabroso.css-eqlu8i{font-size:small;padding-left:4px;} (Cristina Martin-Sabroso)

Publication Activity (10 Years)

Top Topics

Top Venues

Cristina Martín-Sabroso (Cristina Martin-Sabroso)